6 completed. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow Orient Pharma Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia Pitavastatin, Ezetimibe, 1PC111 - Primary Hypercholesterolemia, Mixed Dyslipidemias | Phase 3 | Completed | Orient Pharma Co., Ltd. | 390 | 2020-08-01 | 2022-05-18 |
| Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD ORADUR®-Methylphenidate - Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Orient Pharma Co., Ltd. | 64 | 2016-01-01 | 2021-12-15 |
| Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD Placebo First, then ORADUR®, ORADUR® First, then Placebo - Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Orient Pharma Co., Ltd. | 114 | 2015-06-01 | 2021-12-06 |
| Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis Isoniazid with HUEXC030 and RZE, HRZE - Pulmonary Tuberculosis | Phase 2 / Phase 3 | Completed | Orient Pharma Co., Ltd. | 557 | 2012-12-06 | 2022-06-15 |
| Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia 1PC002, Lipitor - Hypercholesterolemia | Phase 3 | Completed | Orient Pharma Co., Ltd. | 202 | 2011-11-01 | 2023-07-17 |
| A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease oxybutynin and clonidine oral solution treatment A, oxybutynin and clonidine oral solution treatment B, oxybutynin and clonidine oral solution treatment C - Sialorrhoea | Phase 2 | Completed | Orient Pharma Co., Ltd. | 24 | 2011-08-01 | 2023-04-10 |
Attention Deficit Disorder with Hyperactivity (2) · Hypercholesterolemia (1) · Parkinson Disease (1) · Sialorrhea (1) · Tuberculosis, Pulmonary (1)
pitavastatin (2) · Atorvastatin (1) · Ezetimibe (1) · Isoniazid (1) · NSC 366140 (1) · oxybutynin (1)
Taiwan (5) · Australia (1) · New Zealand (1) · United States (1)
Chi-Tai Chang, PhD (2) · Aaron L Ellenbogen, DO, MPH (1) · Chen-Huan Chen (1) · Chiau-Suong Liau (1) · Dee Pei (1) · Huey-Herng Sheu (1) · Ju-Chi Liu (1) · Ming-Shien Wen (1) · Shirley Lin (1) · Wei-Shiang Lin (1) · Wen-Pin Huang (1) · Yu-Pu Hu, PhD (1)